US › Healthcare

LakeShore Biopharma Co., Ltd (LSBCF)

US · Healthcare · Biotechnology

$0.070.00%

Last close · 2026-08-04

Latest quarter · ended 2024-06-30

Revenue

$135.5M

Revenue YoY

+27.7%

Net profit

$-181.4M

Profit YoY

-63.3%

EPS

$-13.40

EPS estimate

$-5.80

Net margin

-133.9%

EPS came in at -13.40 against a street estimate of -5.80 — a miss of 131.0%.

Key statistics

Market cap

$2.8M

Forward P/E

0.0

P/B

0.04

Book value

$3.55

EPS (TTM)

$-0.77

52-week high

$0.90

52-week low

$0.03

50-day MA

$0.06

200-day MA

$0.43

Beta

1.01

Shareholding

Insiders

88.42%

Institutions

1.47%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for LakeShore Biopharma Co., Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.